Area of research
Toxicology · Pathology and Forensic Medicine
Research interest
Research interests include Forensic Toxicology and Drug Analysis, Alcohol Consumption and Health Effects, Neurotransmitter Receptor Influence on Behavior, and Analytical Chemistry and Chromatography.
Proteome profiling of home-sampled dried blood spots reveals proteins of SARS-CoV-2 infections
Microneedle Patch for Painless Intradermal Collection of Interstitial Fluid Enabling Multianalyte Measurement of Small Molecules, SARS‐CoV‐2 Antibodies, and Protein Profiling
P1528: GENETIC AND PHENOTYPIC CHARACTERIZATION OF HEREDITARY SPHEROCYTOSIS AND RELATED DISORDERS – DESCRIPTION OF 9 NEW GENETIC VARIANTS
Measurement of the alcohol biomarker phosphatidylethanol (PEth) in dried blood spots and venous blood—importance of inhibition of post-sampling formation from ethanol
Sensitive determination of ethyl glucuronide in serum and whole blood: detection time after alcohol exposure compared with urine
Elimination Characteristics of the Alcohol Biomarker Phosphatidylethanol (PEth) in Blood during Alcohol Detoxification
Dose–Response Characteristics of the Alcohol Biomarker Phosphatidylethanol (PEth)—A Study of Outpatients in Treatment for Reduced Drinking
High-Yield Passive Plasma Filtration from Human Finger Prick Blood
Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long‐term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics
Intoxications involving acrylfentanyl and other novel designer fentanyls – results from the Swedish STRIDA project
Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats
Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project
Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays
Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project
Development and application of a multi-component LC–MS/MS method for determination of designer benzodiazepines in urine
Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes
Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project
Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project
Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine
Phencyclidine analog use in Sweden—intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project
Potential of Mass Spectrometry in Developing Clinical Laboratory Biomarkers of Nonvolatiles in Exhaled Breath
Intoxications involving MDPV in Sweden during 2010–2014: Results from the STRIDA project
MT-45, a new psychoactive substance associated with hearing loss and unconsciousness
Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project
Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project
Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24‐week randomized placebo‐controlled trial
Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma
Detection of drugs of abuse in exhaled breath using a device for rapid collection: comparison with plasma, urine and self-reporting in 47 drug users
Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA project
Therapeutic drug monitoring for tomorrow